Cargando…

Bone-kidney axis: A potential therapeutic target for diabetic nephropathy

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). However, its pathogenesis remains unclear, and effective prevention and treatment strategies are lacking. Recently, organ-to-organ communication has become a new focus of studies on pathogenesis. Various organs or tiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ming, Luo, Shilu, Yang, Jinfei, Chen, Wei, He, Liyu, Liu, Di, Zhao, Li, Wang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637707/
https://www.ncbi.nlm.nih.gov/pubmed/36353239
http://dx.doi.org/10.3389/fendo.2022.996776
_version_ 1784825246694506496
author Yang, Ming
Luo, Shilu
Yang, Jinfei
Chen, Wei
He, Liyu
Liu, Di
Zhao, Li
Wang, Xi
author_facet Yang, Ming
Luo, Shilu
Yang, Jinfei
Chen, Wei
He, Liyu
Liu, Di
Zhao, Li
Wang, Xi
author_sort Yang, Ming
collection PubMed
description Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). However, its pathogenesis remains unclear, and effective prevention and treatment strategies are lacking. Recently, organ-to-organ communication has become a new focus of studies on pathogenesis. Various organs or tissues (the liver, muscle and adipose tissue) secrete a series of proteins or peptides to regulate the homeostasis of distal organs in an endocrine manner. Bone, an important part of the body, can also secrete bone-derived proteins or peptides that act on distal organs. As an organ with high metabolism, the kidney is responsible for signal and material exchange with other organs at any time through circulation. In this review, we briefly discussed bone composition and changes in bone structure and function in DN and summarized the current status of bone-derived proteins and their role in the progression of DN. We speculated that the “bone-kidney axis” is a potential target for early diagnosis and treatment of DN.
format Online
Article
Text
id pubmed-9637707
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96377072022-11-08 Bone-kidney axis: A potential therapeutic target for diabetic nephropathy Yang, Ming Luo, Shilu Yang, Jinfei Chen, Wei He, Liyu Liu, Di Zhao, Li Wang, Xi Front Endocrinol (Lausanne) Endocrinology Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). However, its pathogenesis remains unclear, and effective prevention and treatment strategies are lacking. Recently, organ-to-organ communication has become a new focus of studies on pathogenesis. Various organs or tissues (the liver, muscle and adipose tissue) secrete a series of proteins or peptides to regulate the homeostasis of distal organs in an endocrine manner. Bone, an important part of the body, can also secrete bone-derived proteins or peptides that act on distal organs. As an organ with high metabolism, the kidney is responsible for signal and material exchange with other organs at any time through circulation. In this review, we briefly discussed bone composition and changes in bone structure and function in DN and summarized the current status of bone-derived proteins and their role in the progression of DN. We speculated that the “bone-kidney axis” is a potential target for early diagnosis and treatment of DN. Frontiers Media S.A. 2022-10-24 /pmc/articles/PMC9637707/ /pubmed/36353239 http://dx.doi.org/10.3389/fendo.2022.996776 Text en Copyright © 2022 Yang, Luo, Yang, Chen, He, Liu, Zhao and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Yang, Ming
Luo, Shilu
Yang, Jinfei
Chen, Wei
He, Liyu
Liu, Di
Zhao, Li
Wang, Xi
Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
title Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
title_full Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
title_fullStr Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
title_full_unstemmed Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
title_short Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
title_sort bone-kidney axis: a potential therapeutic target for diabetic nephropathy
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637707/
https://www.ncbi.nlm.nih.gov/pubmed/36353239
http://dx.doi.org/10.3389/fendo.2022.996776
work_keys_str_mv AT yangming bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy
AT luoshilu bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy
AT yangjinfei bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy
AT chenwei bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy
AT heliyu bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy
AT liudi bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy
AT zhaoli bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy
AT wangxi bonekidneyaxisapotentialtherapeutictargetfordiabeticnephropathy